Physician profile
Dennis Samuel
NPI 1932102944
$2,672.25
in general payments reported to CMS, 2019-2025
33 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $227 · 2021: $327 · 2022: $564 · 2023: $400 · 2024: $348 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $664.41 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $460.36 | 2019-2024 | Lo Loestrin Fe, Liletta, Orilissa |
| Sumitomo Pharma America, INC. | $233.78 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $178.30 | 2020-2024 | Slynd |
| Sage Therapeutics, LLC | $144.03 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $120.68 | 2022 | |
| Pfizer INC. | $113.30 | 2019-2024 | |
| Boston Scientific Corporation | $77.41 | 2025 | General - Female Sui |
| Therapeuticsmd, INC. | $64.28 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $59.67 | 2025 | |
| Aspira Women'S Health INC | $57.86 | 2022 | |
| Avion Pharmaceuticals | $57.68 | 2019-2021 | |
| Shield Therapeutics INC | $51.50 | 2024 | |
| Duchesnay USA Incorporated | $46.25 | 2019 | |
| Hologic Sales and Service, LLC | $41.10 | 2020-2023 | Acessa Provu System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $37.29 | 2019-2023 | Gardasil 9 |
| Allergan, INC. | $24.10 | 2019 | |
| Daiichi Sankyo INC. | $22.98 | 2022 | |
| Applied Medical Resources Corporation | $22.33 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.16 | 2022 | |
| Organon LLC | $18.62 | 2024 | |
| Intuitive Surgical, INC. | $16.93 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.29 | 2019 | |
| Baxter Healthcare | $16.14 | 2020 | |
| Coloplast Corp | $16.08 | 2023 | Supris |
| Coopersurgical, INC. | $15.51 | 2024 | Sos |
| Axonics, INC. | $15.45 | 2022 | |
| Roche Diagnostics Corporation | $13.59 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.19 | 2019 | |
| Minerva Surgical, INC | $11.08 | 2019 | |
| Convatec INC. | $11.06 | 2021 | |
| Amgen INC. | $10.84 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.